false
OasisLMS
Catalog
Arrhythmias in Pregnancy
Arrhythmias in Pregnancy
Arrhythmias in Pregnancy
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The session on arrhythmias in pregnancy explored various facets of managing cardiac complications during pregnancy, based on the 2023 Expert Consensus Statement. Dr. Jose Joglar began by discussing the increasing incidence of arrhythmias in pregnant women and highlighted that normal hemodynamics must remain the treatment priority. He identified common arrhythmias, such as PACs and sinus tachycardia, while stressing that most arrhythmias are benign but must be monitored due to potential risks to both mother and fetus.<br /><br />Dr. Alexis Tomolo covered the medical management of arrhythmias, underscoring the importance of a comprehensive care team throughout the pregnancy stages. She noted that while most medications used for non-pregnant patients are applicable, beta-blockers are generally preferred, with special attention needed for patients with specific cardiac conditions, such as Brugada Syndrome and Long QT Syndrome.<br /><br />Dr. Tess Sorrell discussed fetal arrhythmias diagnosed via echocardiograms and emphasized early collaboration with cardio-obstetric teams. She highlighted that fetal arrhythmias, although common, require careful management to prevent complications such as hydrops fetalis and recommended treatments and interventions where appropriate.<br /><br />Dr. Jennifer Wright addressed invasive treatment, such as cardioversion and ablation, emphasizing that timely, informed decision-making and minimizing radiation exposure are crucial. She detailed the effectiveness and safety of cardioversion, ablation, and device implants during pregnancy, advocating for reducing risks through strategic procedural planning.<br /><br />The session concluded with a Q&A, touching on topics like sedation strategies, cardioversion risks, and device implantation, reinforcing the overarching message to manage pregnant patients as diligently as non-pregnant patients while accounting for maternal and fetal safety.
Keywords
arrhythmias
pregnancy
cardiac complications
hemodynamics
beta-blockers
fetal arrhythmias
cardioversion
ablation
Brugada Syndrome
Long QT Syndrome
×
Please select your language
1
English